IBIO: Arkowitz David reports a stock award
By AlphaYouPublished Form 4
Arkowitz David
Reporting filer
Arkowitz David reports a stock award, not an open-market purchase or sale, in iBio, Inc.. Form 4 filed Oct 15, 2026 lists 1 entry.
- Disclosed
- Oct 15, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) (derivative) | Arkowitz David | 2026-10-14 | A | Grant or award | 38000 | 0 | 38,000 | 1 day | Filed terms
|
Stock Option (right to buy) (derivative)
- Owner
- Arkowitz David
- Date
- 2026-10-14
- Code
- A
- Action
- Grant or award
- Quantity
- 38000
- Price
- 0
- Following holdings
- 38,000
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- id: F1
- conversion Or Exercise Price: 0.78
- transaction Date: 2026-10-14
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 38000
- id: F1
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-10-13
- underlying Security Title: Common Stock
- underlying Security Shares: 38000
- shares Owned Following Transaction: 38000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Arkowitz David: Director.
- F1: The options vest pro rata in monthly installments over twelve months, with the first installment vesting one month after the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.